Siga Technologies (SIGA) Cash from Investing Activities (QoQ) (2010 - 2025)
Powered by 
Analysis
Siga Technologies (SIGA) Cash from Investing Activities (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Siga Technologies | 235.60 Mn | 80.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -28,957,500.00% |
| Jun 30, 2025 | 100.00% |
| Mar 31, 2025 | -39.55% |
| Dec 31, 2024 | 20.46% |
| Sep 30, 2024 | -926.41% |
| Jun 30, 2021 | 22.03% |
| Mar 31, 2020 | -774,950.00% |
| Dec 31, 2019 | 99.99% |
| Sep 30, 2019 | -671,566.67% |
| Jun 30, 2019 | 100.03% |
| Mar 31, 2019 | -100.01% |
| Dec 31, 2017 | -207.60% |
| Sep 30, 2017 | 62.07% |
| Dec 31, 2016 | 119,966,000.00% |
| Sep 30, 2016 | 100.04% |
| Jun 30, 2016 | 70.23% |
| Mar 31, 2016 | 81.49% |
| Dec 31, 2015 | 27.51% |
| Mar 31, 2015 | 185,973.61% |
| Dec 31, 2014 | 99.95% |